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Abstract: Bacterial infections represent a serious threat in modern medicine. In particular, biofilm
treatment in clinical settings is challenging, as biofilms are very resistant to conventional antibiotic
therapy and may spread infecting other tissues. To address this problem, biosensing technologies are
emerging as a powerful solution to detect and identify bacterial pathogens at the very early stages of
the infection, thus allowing rapid and effective treatments before biofilms are formed. Biosensors
typically consist of two main parts, a biorecognition moiety that interacts with the target (i.e., bacteria)
and a platform that transduces such interaction into a measurable signal. This review will focus on
the development of impedimetric biosensors using antimicrobial peptides (AMPs) as biorecognition
elements. AMPs belong to the innate immune system of living organisms and are very effective in
interacting with bacterial membranes. They offer unique advantages compared to other classical
bioreceptor molecules such as enzymes or antibodies. Moreover, impedance-based sensors allow the
development of label-free, rapid, sensitive, specific and cost-effective sensing platforms. In summary,
AMPs and impedimetric transducers combine excellent properties to produce robust biosensors for
the early detection of bacterial infections.
Keywords: antimicrobial peptides; bacteria; biofilm; bacterial detection; biosensors; impedance
1. The Burden and Risks of Bacterial Infections
Bacteria mainly survive as multicellular aggregates known as biofilms, which are involved in at
least two thirds of all infections and exhibit rising adaptive resistance to conventional antibiotic
therapies [1]. Biofilm infections require complex and costly clinical treatments and can lead to
morbidity and mortality in patients. Specifically, the World Health Organization (WHO) identified
lower respiratory tract infections as the fourth-highest cause of death worldwide, with diarrheal
diseases (ninth), and tuberculosis (tenth) being among the top 10 leading causes of death in 2016 [2].
Among patients that are vulnerable to suffer an infection, those bearing medical devices such
as catheters, artificial heart valves, prosthetic joints, and other implants, are more susceptible to
develop a biomaterial associated infection (BAI). One factor contributing to the onset of BAI is the
decreased efficacy of the local immune defense induced by a foreign body (i.e., the medical device).
In agreement, the number of bacteria required to cause an infection is significantly lower in the
presence of an implant. Another important factor is the predilection of bacteria to adhere to a substrate,
where they can replicate, and form a biofilm from which they can invade the surrounding tissues and
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cause an infection. Conventional antibiotic therapy often fails due to the low levels of antibiotic at
the site of infection, and, consequently, removal of the biomaterial is the last option to control the
infection [3]. This underlines the pressing need for more specific and faster alternative strategies that
can be employed to diagnose and prevent BAI [4].
Therefore, the early detection and identification of bacterial pathogens remain a high priority goal.
Biofilms form and spread rapidly, thus a fast detection often means the difference between life and
death for the patient. Moreover, specificity is also needed to select an appropriate clinical treatment or
to carefully assess the danger to the public [5].
The identification and quantification of bacteria has traditionally been performed using a variety
of time-consuming methods, which required specialized laboratories and costly equipment. Typically,
analytes (e.g., blood, saliva, urine, or food samples) are analyzed using various techniques, namely,
microscopical observation, cell culture, biochemical and immunological tests, or genetic analysis.
However, all methods have limitations. Microscopy is relatively quick but not specific, and requires the
staining of bacteria. Culturing and growing bacteria on agar can take up to several days. Furthermore,
not all bacteria can be cultured in the laboratory [4]. Biochemical assays and immunological tests
(such as ELISA) are good methods to detect specific bacterial markers. However, these methods are
time consuming and costly, and require skilled personnel to run the tests and interpret the results [5].
Further testing by means of genetic analysis has enabled a more efficient identification of bacterial
strains. PCR is a highly sensitive technique that relies on the use of bacterial genetic material. It does
not require culturing bacteria due to the small sample needed, but it is still a tedious and expensive
procedure, which can last for days. Real-time PCR analysis can be completed faster, within several
hours, but it still depends on specialized equipment (costly) and trained users. Moreover, it entails
sample enrichment and purification prior to analysis (complex) [6].
Hence, there is an urgent demand for more rapid, cost-effective, and sensitive methods, which can
detect and identify bacteria or its components. In this regard, biosensors have recently been looked
upon as attractive alternatives to the existing methods to detect pathogens. Biosensors show excellent
properties, including high sensitivity, specificity and reproducibility, without the need for sample
preparation steps. Furthermore, they are cheap and fast, which would allow the doctor to quickly
ascertain an infection and prescribe an appropriate treatment [4–8].
The versatility of biosensors is also illustrated by the large number of targets they can detect,
including bacteria [5,9], viruses [10] and a variety of biomolecules such as specific DNA sequences [11],
proteins [12,13] and peptides [14].
The aim of this review is to present the state of the art and recent advances in the field of biosensors
for bacterial detection. We will particularly focus on the use of antimicrobial peptides (AMPs) as
biorecognition moieties for the electrochemical (impedance-based) detection of bacteria.
2. Biosensors for Detecting Bacterial Cells
A biosensor is defined as any measuring device that incorporates a biological entity in
order to recognize a target molecule and produce a detectable signal. Biosensors combine the
outstanding selectivity of biological interactions found in nature with the processing power of modern
microelectronics, and are nowadays used in a variety of fields including medicine, environmental
studies, food and processing industries.
A biosensor typically encompasses two major components, a biorecognition moiety and
a transduction platform (Figure 1), together with an amplifier system and a signal processer [8,15].
Biorecognition elements are commonly biomolecules such as antibodies, enzymes or peptides that are
able to recognize and interact with high specificity with a target analyte. Upon interaction, a catalytic
or binding event is produced. This process is converted by the transduction platform into a measurable
signal, which is proportional to the analyte concentration.
Response time, dynamic range, limit of detection (LoD), single-to-noise ratio, and specificity are
important features that need to be optimized to obtain an adequate biosensor. These parameters are
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strongly related to the elected biological sensing element, the transducer and the signal amplifier [9].
Thus, to efficiently detect bacteria, it will be crucial to select biorecognition elements with high affinity
for bacterial components, and an appropriate system of transduction to ensure detectable signals are
generated, even at very low concentrations of bacteria. The following sections will cover both elements.
Additionally, it should be noted that there are other aspects that can influence the sensitivity and
specificity of a biosensor. In particular, material-dependent unspecific bacterial adhesion as well as
adhesins and bacteria-secreted extracellular polymeric substances (EPS) may greatly limit the detection
efficiency and performance of the sensor. For example, it has been observed that microorganisms
attach with higher preference to hydrophobic surfaces and plastics such as Teflon, compared to more
hydrophilic substrates like glass or metal [16]. Moreover, it has also been described that most bacteria
produce EPS and adhesins to promote bacterial attachment [17,18]. This means that bacteria may
attach to the biosensor surface regardless of the biorecognition element. Such non-specific attachment
is often neglected in biosensor studies and emphasizes the importance of utilizing low fouling surfaces
(e.g., polymers like polyethylene glycol) to block unspecific protein and bacterial adhesion [19].
Two classes of biosensors have been developed to detect bacteria: (i) those which require sample
processing (e.g., bacterial lysis) to liberate bacterial components, and (ii) processing-free systems,
which target whole bacteria. In the first category, bacterial components such as DNA [11], RNA [20],
coagulation factors [12], and exotoxins [21] can be detected. Its main disadvantage is the requirement
for sample processing, which increases the time and cost of the analysis. Therefore, biosensors
allowing the direct detection of whole bacteria without the need of extra pre-treatments or reagents
are a preferred strategy, as they are generally faster and more cost-effective. In this review we will
focus on label-free sensors capable of detecting whole bacteria.
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Figure 1. Schematic representation of the biosensing process. A biosensor has two main components:
a biorecognition moiety that interacts with analytes and a transducer that converts such interaction
into a measurable signal.
2.1. Biorecognition Elements
As previously explained, biorecognition moieties are crucial elements in a biosensor (Figure 1),
as they rve to ide tify the target analyt and determin the efficiency of the biose sor i terms of
bo sensitivity and specificity. Thus, the c oice of the recognition el ment will strongly influence the
performance of th sens r. Besides a high binding affinity for the target analyte, these elements should
also have a good stability [22].
The list of biological entities th t can be used to develop a biosensor is expanding rapidly,
as the technology of biosensing methods advances. For bacterial detection, virtually any molecule
that recognizes or attaches to a bacterial cell can potentially be used in a biosensor. The variety of
elements ranges from small molecules, such as sugars and short peptides, to large molecules including
proteins, and even viruses and cells. Representative examples are schematically shown in Figure 2.
A comprehensive classification can be found in the recent literature [22,23].
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Biorecognition probes can be classified according to different criteria. If the origin is selected as
such criterion, two major categories can be used: those elements found in nature, and those designed
and engineered by men. Obviously, overlapping between these two families exist, and many strategies
often focus on recognition elements from nature that are modified in the lab. There is no perfect
candidate. Biological elements such as cells and large proteins typically show higher specificity
for bacteria than small biomolecules, but their complexity is accompanied by reduced stability and
difficulties in handling. Synthetic molecules, on the contrary, are useful in a way that their binding
affinity can be optimized, while retaining good stability under testing conditions.
Enzymes and antibodies are two common examples of biorecognition elements from natural
origin and are widely used in biosensing technologies. While enzymatic biosensors rely on the reaction
of an enzyme with its substrate (e.g., the substrate is metabolized by the enzyme or it inhibits the
enzymatic reaction), immunosensors (sensors coated with antibodies) interact with antigens present on
microbial surfaces. Both approaches have good levels of specificity and can be produced at relatively
low cost. However, they have limitations in terms of storage, handling and stability. Specific problems
also exist for each system. Enzymatic biosensors commonly contain only one enzyme and cannot be
used for the detection of whole bacteria, and achieving a good signal enhancement for small molecules
is not always possible with antibodies [24].
Lectin/carbohydrate recognition can also be exploited to detect bacteria. Lectins, which are
proteins that recognize carbohydrates, can be used to specifically react with bacterial carbohydrates [25].
It should be noted that the opposite approach, i.e., functionalizing the sensor with sugars and detecting
bacterial lectins, is also possible [23] In this regard, carbohydrate-based sensors are an attractive
alternative due to the chemical stability of carbohydrates and good grafting properties. Nonetheless,
the detection of bacterial species using these molecules can produce false positives in complex samples
because several lectins can bind different carbohydrates, as well as different carbohydrates can bind
the same lectin, thus causing a significant reduction in specificity.
More complex entities, e.g., living systems, represent alternative biorecognition elements. This is
the case of human cells. Mammalian cells express a wide range of proteins and receptors to
perceive their environment, which make them appealing bioreceptors to sense bacteria [21,26,27].
Bacteriophages may fall within this category as well. Bacteriophages, or simply phages, are viruses
that infect and replicate within bacteria. As such, they possess highly specific mechanisms to
recognize bacteria and can be used for bacterial detection [23,28]. Interestingly, a key feature of
phage-based sensors is their ability to distinguish between viable and inactive bacteria, as they can
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only replicate within viable bacterial cells. Despite the advantages offered by these two approaches,
several limitations are associated to their use, including their particularly difficult handling and
immobilization on the biosensor, together with their low stability over time [29,30].
The last example of this category is antimicrobial peptides (AMPs). AMPs are members of
the innate immune system of many organisms and, hence, are very effective in killing a wide
range of pathogens, including Gram positive and Gram negative bacteria, viruses, fungi and even
cancerous cells [31]. Relatively short in size and generally cationic and amphipathic, these peptides
commonly interact with bacterial cell membranes through electrostatic interactions, and subsequently
disrupt membrane integrity via hydrophobic contacts [32]. This bactericidal mechanism is less likely
to be overcome by bacterial resistance than conventional antibiotic treatment, and for this reason
AMPs are being considered as very promising therapeutic targets [33]. In addition to their broad
biological potential, AMPs show intrinsic stability and can be produced by synthetic methods in large
quantity [34]. It is thus not surprising that these molecules have also been used as bioreceptors for
the sensing of bacteria [35,36], as they show clear advantages over the limitations of other methods.
In this review, we will focus on AMPs as biorecognition elements. Their potential and features will be
covered with greater detail in Section 3.
As previously commented, a second class of biorecognition elements would be those that have
been engineered to very effectively recognize bacteria but with higher stability than classical recognition
elements such as enzymes or antibodies. These strategies include the use of molecularly-imprinted
polymers (MIPs) [37,38]; phage peptides, which recapitulate only the receptor binding protein (RBP)
localized on the phage tail and responsible for bacterial recognition [30]; affibodies or engineered
antibody mimetics with high target affinity [36,39]; and aptamers, short oligonucleotide molecules
that unlike their natural counterparts (i.e., DNA and RNA) can bind to whole bacteria. Aptamers are
produced by repeated rounds of in vitro selection using systematic evolution of ligands by exponential
enrichment (SELEX) [40]. This method allows engineering aptamers with high affinity and specificity
for bacteria [41]. These and other approaches have potential to replace classical strategies to develop
novel biosensors with improved performance. However, their use as biosensing motives is still in
some cases at an early stage of research and further studies in this direction are required.
2.2. Transduction Systems
Once bacteria have been recognized by the biosensing moiety, it is necessary to convert this
interaction into a measurable signal. This is achieved by a suitable transduction platform (Figure 1).
There are many different types of transduction systems, which can be categorized according to the
nature of the signal transduced. Electrochemical, optical, mechanical and thermal transducers are the
most common types (Figure 3).
Impedimetric and optical sensors are nowadays frequently used to detect whole bacteria [4,23,42];
however, multiple combinations between bioreceptors and transducers are possible, giving rise to
a very large number of biosensors for whole bacteria detection (Table 1). The following section
briefly describes the main families of transducers used in the field, together with relevant examples
of biosensing.
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Table 1. Examples of different combinations between biorecognition elements and transducers to
obtain biosensors for bacterial detection.
Transducer
Optical Mechanical Electrochemical
Adhesin (Ad) or None — Ad + Nanowires [18] —
B
ioreceptor
Enzyme (Ez)
(i) Ez NP + colorimetric [43]
(ii) Bacteria-specific Ez +
colorimetric [44]
— Ez NP + DPV [45]
Antibody (Ab) (i) Ab + MNP + SPR [46](ii) Ab + SPR [47]
(i) Ab + QCM [48]
(ii) Ab + nanobeads + QCM
[49]
(iii) Au NP + Ab + QCM
[50,51]
(iv) Ab + cantilever [52]
(v) Ab + PEMC [53]
(i) Ab + amperometric [54,55]
(ii) Ab+ impedimetric
[14,56–60]
(iii) Ab MNP + DPV [61]
(iv) Ab Mbeads +
amperometric [54,55,62]
DNA/RNA/
Aptamer
(Ap)/Aptazyme (Apz)
(i) Ap + colorimetric [63,64]
(ii) Ap + LSPR [65]
(iii) Apz + Mbeads +
colorimetric [66]
(i) thssDNA + QCM [67]
(ii) ssDNA + cantilever [68]
(i) Ap + potentiometric [69,70]
(ii) Ap + impedimetric [71]
Lectin (L) L + SPR [72] L + piezoelectric [73,74] L + impedimetric [75–77]
Phage (Ph)
(i) Ph + SPR [78,79]
(ii) Ph + MES + colorimetric
[80]
(iii) Ph + Mbeads +
colorimetric [81]
(i) Ph + QCM [82]
(ii) Ph + MES [83–86]
(i) Ph + amperometric [87]
(ii) Ph + impedimetric
[57,88–90]
AMP AMP + fluorescencespectroscopy [91–94] AMP + QCM [95,96]
AMP + impedimetric
[95,97–105]
MES: magnetoelastic sensor; NP: nanoparticle; MNP: magnetic NP; SPR: surface plasmon resonance; LSPR: Localized
SPR; QCM: quartz crystal micro-balance; AMP: antimicrobial peptide; PEMC: piezoelectric-excited millimeter-size
cantilever; DPV: differential pulse voltammetry; Mbeads: magnetic beads; thssDNA: thiolated single-stranded
DNA; ssDNA: single-stranded DNA.
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2.2.1. Mechanical Transducers
Mechanical biosensors commonly operate measuring variations in the vibrational frequency of
a piezoelectric crystal, which can be correlated to small changes in mass, e.g., the binding of a bacteria
to a surface [106]. Mechanical biosensors are label-free and have high sensitivity and fast processing
times. Among the large quantity of mechanical sensors existing at present [107], pathogenic bacteria
are mainly detected using quartz crystal microbalance (QCM) or cantilever technology (Figure 3).
QCM sensors have been combined with various types of bioreceptors to detect whole bacterial
cells (Table 1), including antibodies [48–51], DNA molecules [67], lectins [73,74], AMPs [95,96] or
phages [82]. The potential of AMPs has been highlighted in recent examples. For example, Shi et al.
reported a biosensor using the AMP pleurocidin combined with single-walled carbon nanotubes
(SWCNT) on a multichannel quartz crystal [96]. This AMP provided a broad spectrum of antibacterial
activity with almost no effect on eukaryotic cells (e.g., erythrocytes). Interestingly, the interaction of
pleurocidin with bacteria was associated with the detachment of the AMP from the SWCNT, resulting
in a measurable change in the sensor frequency. This method allowed a real-time, sensitive and fast
(only 15 min) detection of bacteria.
The second type of mechanical transducers is based on microcantilever technology. This technique is
label-free, very sensitive, fast and can be miniaturized. Therefore, these transducers are ideal candidates for
the development of point-of-care biosensors. Bacterial detection with microcantilevers has been described
using either antibodies [52] or DNA [68] as biorecognition elements. Nevertheless, the performance of
these sensors in complex matrixes has not been reported yet [4]. Noteworthy, the recently developed
piezoelectric-excited millimeter-size cantilevers (PEMC) coupled to antibodies have been able to detect
Listeria monocytogenes at infectious doses, both in PBS buffer and milk samples [53].
In addition to the well-known QCM and cantilever methods, nanowire-based sensors are emerging
as new platforms with very high sensing potential (i.e., single molecule detection) [108]. For instance,
nanowire arrays mechanical sensors were recently described to study bacterial adhesion at the single
cell level [18]. This technique does not rely on the use of biorecognition elements, although the
nanowires can be functionalized with proteins like adhesin to enhance bacterial attachment forces.
Such new sensing platforms are interesting because they open the way to dissect the mechanisms of
bacterial attachment at the biophysical level.
2.2.2. Optical Transducers
Optical biosensors detect changes in the properties of light as a result of the interaction between
an analyte and a bioreceptor. They allow highly specific and sensitive sensing of bacteria in a rapid,
real-time and cost-effective fashion. In general, they can be divided into label-based (e.g., fluorescent)
and label-free methods [109,110]. Plasmonic biosensors, relying on the use of surface plasmon
resonance (SPR) or surface enhanced Raman spectroscopy (SERS), are nowadays frequently used
for pathogen detection (Figure 3) [42]. These transducing systems can be combined with diverse
bioreceptors including antibodies, phages and lectins to efficiently detect whole bacteria (Table 1).
For example, SPR-based sensors containing different lectins as recognition units were able to detect
E. coli 0157:H7 with a LoD of 3 × 102 CFU/mL [72]. Interestingly, the detection of multi-resistant
pathogens has been achieved using phages, sensing bacteria at concentration of 103 CFU/mL in
less than 20 min [78,79], and with antibodies specific to antimicrobial resistance-related protein
(e.g., anti-penicillin binding protein 2A, PBP2a) [47]. SERS has also been widely used to detect
pathogens due to its single molecule-level sensitivity and molecular specificity [111,112]. The main
limitation of this method is the need of specialized software and a database with SERS spectra of
bacteria, which has prevented its widespread use.
Another technique derived from SPR is localized SPR (LSPR), which involves a resonant oscillation
at the surface of a metal nanoparticle under the incidence of an external light. Due to the unique
properties of LSPR, gold nanoparticles (AuNPs) modified with antibodies have been widely used to
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develop bacterial biosensors [46,65]. However, commercialization of this technique has been limited
because it requires skilled operators and sophisticated instruments.
Colorimetric assays are an attractive alternative to overcome the aforementioned limitations and
can be developed into portable, easy-to-use, and user-friendly devices for in situ analysis. Examples
of colorimetric sensing of bacteria at low concentrations include the use of cationic AuNPs bound to
enzymes [43] or paper-based analytical devices (µPAD) [44]. A variety of DNA aptamers coupled to
quantum dots or to magnetic nanoparticles (MNPs) were also developed against different bacterial
strains with high sensitivity [63,64]. Other described combinations are phage-based magnetoelastic
(MES) biosensors [80,81] and aptazymes combined with magnetic beads [66]. The use of AMPs
as biorecognition elements in optical devices is usually based on fluorescence microscopy [91–94].
For instance, magainin I-coated glass microspheres (GMs) on a microfluidic sensor were used to
detect E. coli with very good efficiency [93]. This was achieved owing to the high specific surface area
provided by GMs, which ensured a great number of AMP-bacteria interactions.
2.2.3. Electrochemical Transducers
Electrochemical biosensors represent the most widespread class of sensors for bacterial biosensing,
and are based on the use of current, potential and impedance changes to transduce the biological
recognition event. Compared to other analytical techniques, electrochemical detection has the
advantage of being inexpensive, robust, fast and relatively simple to operate. Another interesting
feature is that in general this method does not require sample preparation as the biological sensing is
highly selective and the signal is provoked by electrochemical and physical changes on a conducting
polymer layer. Electrochemical biosensors usually contain three electrodes (a reference electrode,
a working electrode, and a counter electrode) and are classified according to the electrical parameter
measured as (i) amperometric, (ii) potentiometric or (iii) impedimetric types.
Amperometric biosensors operate by generating a current signal when a potential is applied
between the working and the reference electrodes. The current depends on the analyte concentration.
Enzyme-based amperometric sensors were reported 40 years ago for the detection of glucose [113],
but now can be applied to sense a wide range of analytes, including whole bacteria [54]. As shown in
Table 1, in addition to enzymes, amperometric sensors can be developed by combination with other
bioreceptors such as antibody-conjugated magnetic particles [54,55,62] or phages [87], among others.
Potentiometric biosensors are based on the potential difference (voltage) between the working and
reference electrodes. The electrical potential is proportional to the analyte concentration, which is compared
to a reference potential (reference electrode). Thus, this technique relies on the sensitivity and selectivity
of the working electrode and requires a stable and accurate reference electrode. Although potentiometry
is widely used in the biosensor field, examples of potentiometric biosensors for the detection of whole
bacterial cells are scarce. This is due to the fact that, unlike other methods such as impedance, potentiometry
cannot provide specific and sensitive signals for large analytes such as bacteria. However, some innovative
approaches using aptamers as bioreceptors have resulted in reasonably good LoD [69,70].
Finally, impedimetric biosensors measure changes in impedance over a suitable frequency
range. In this case, the analyte interaction is translated into a change in the resistance and/or
double-layer capacitance [114]. Compared to amperometric and potentiometric methods, sensors
based on impedance have important advantages for the detection of whole bacteria: they are label-free,
economic, highly sensitive, and can be miniaturized. Moreover, they are not affected by the presence
of other compounds in the sample matrix [6,9]. Their main disadvantage is that any charged molecule
can lead to a change in conductivity, thus affecting the selectivity of the sensor [15]. The typical
experimental setup used in impedance biosensors is a three-electrode configuration, where the test
signal is applied between the working and reference electrodes, while the current is measured at
the counter electrode [115]. A large number of impedimetric biosensors for whole bacteria detection
have been described in recent years (Table 1). The most common bioreceptors employed in this case
are enzymes coated on nanoparticles [45], antibodies [14,57–60], aptamers [71], lectins [75–77] and
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phages [88,89]. The use of AMPs represents the main focus of this review and will be covered
comprehensively in the following sections.
2.3. Signal Amplifiers
Signal amplification is used to improve the sensitivity of biosensors towards the detection of
the desired target, e.g., bacterial cells. In this sense, the use of nanomaterials such as nanoparticles
has drawn interest due to their remarkable optical and electrical properties (good conductivity and
photoelectrochemical activity) and large surface/volume ratio. Nanomaterials can be used to recreate
an optimal microenvironment that retains the biologically-active conformation of the molecules or to
present multiple copies of the bioreceptor, assuring an optimal signal transduction and the stability of
the biosensor [29]. This strategy can be exploited to obtain sensors with high affinity to detect a large
number of analytes, including bacterial components and whole bacteria.
Examples of (nano-)materials that can be used as signal amplifiers for bacterial detection
are carbon nanotubes (CNT), bio-compatible metal/metal oxide nanoparticles (e.g., AuNPs),
gold nanorods, quantum dots, graphene-based materials and magnetic nanoparticles [22,98,116].
For example, a common strategy of signal amplification is to immobilize enzymes or antibodies on
nanoparticles/nanobeads (Table 1) [49,61]. It is expected that the unique properties offered by these
nanomaterials will allow developing of a new generation of nanostructured devices with increased
potential to detect bacteria [23,24].
3. AMP-Based Impedimetric Biosensors
The next and last section of this review will focus on biosensors that contain AMPs as
biorecognition molecules and rely on impedimetric signal transduction. Such types of biosensors have
unique properties and are gaining increased popularity in the field. However, other combinations are
also frequent and possible—examples have already been cited in the previous sections and in Table 1.
3.1. AMPs as Biorecognition Elements
As previously introduced, AMPs, also known as host defense peptides, are peptides produced
by a large number of living systems to fight against invading pathogens. Their clinical use to replace
antibiotics is attracting interest, as they have a broad spectrum of antibacterial activity but do not
promote bacterial resistance. Moreover, they have shown potential to modulate the immune response
and promote wound healing [33]. From a structural point of view, they are short (generally < 40 amino
acids), cationic, amphipathic (they combine positively charged residues with hydrophobic ones) and
can adopt diverse secondary structures [31,117].
Although AMPs have diverse mechanisms of antibacterial action, their major targets are
cytoplasmic membranes. In general, they establish electrostatic interactions with lipopolysaccharides
(LPS) and other negatively charged molecules on bacterial membranes, after which hydrophobic
contacts with the lipidic components result in pore formation, disruption of the membrane and
cell lysis [32]. The efficiency of AMPs in recognizing the phosphate groups of LPS has been
exploited to develop biosensing assays to detect, classify, and quantify bacteria [36]. In some cases,
AMPs are also internalized and inhibit vital processes such as protein transcription by binding to
intracellular molecules [32].
From an engineering perspective, AMPs have also desirable properties to design biosensors. They can
be synthesized with current solid-phase peptide synthesis methods in an automated fashion at low cost and
in large quantities. Furthermore, they can be derivatized with chemical groups (i.e., spacers and anchors) to
selectively functionalize diverse surfaces. The incorporation of chemoselective anchoring groups, together
with the small molecular size of the peptides, allows an efficient immobilization on the sensor surface
with high ligand density. Last but not least, AMPs are more stable under harsh environments than other
biomolecules commonly used such as enzymes or antibodies [34].
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However, it should be noted that the use of AMPs is not exempt from limitations. Bacterial detection
in real, complex samples with AMPs is not always possible. Moreover, achieving sensitivity and, especially,
selectivity within different bacterial strains is challenging and requires further investigations.
3.2. EIS Technique
Electrochemical impedance spectroscopy (EIS) is the most common technique among impedimetric
methods. This technique measures the impedance of the system, by means of a scan over a wide
range of potential frequencies. Changes in impedance values respond to physicochemical changes
derived from the binding between the analyte and the bioreceptor. EIS measurements can be performed
with a different number of electrodes in different configurations, usually named as two-, three- and
four-electrode implementations.
EIS experimental data can be modeled with an electrical equivalent circuit (EC), which consists
of resistances and capacitances combined in parallel or serially, as required, that represent different
physicochemical properties [118]. The most used is the so-called Randles circuit (Figure 4A). The values
of the electrical components are extracted from the equivalent electrical model using least-squares
minimization fitting of the EIS spectrum [119]. Checking the variation of impedance components
related to the system properties (e.g., solution composition), it is possible to compare impedance
changes to individual EC components to verify the accurate selection of the EC [120].
To graphically analyze the data, the most common formats are the Bode and Nyquist plots. In these
graphs the logarithm of the absolute impedance (log |Z|) and the phase shift (ϕ) are represented as
a function of the logarithm of the excitation frequency f. In particular, in Nyquist plots, data are represented
as the real component of impedance (Zre) on the x axis, and the imaginary component (Zim) on the y axis
(Figure 4B) [4].
Different behaviors are obtained depending on the frequency range. For low frequency values,
the dominant effect is ion diffusion (Warburg impedance) and the plot is represented by a straight line
with a slope of 45◦. On the other hand, at high frequencies the plot is described by a semi-circle with
a diameter that is given by the charge transfer resistance Rct—owing to a bigger value of diffusion time
constant compared to the signal period. Rct is the parameter most used to estimate bacterial concentration:
when bacterial cells bind to the bioreceptors at the surface of the working electrode, the redox reaction is
hindered and Rct increases [105]. Sometimes, however, the double layer capacitance Cdl is used instead [115].
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In terms of bacterial detection, capacitive sensors such as interdigitated electrodes (IDEAs) have
gained special interest in the field in recent years [121,122].
These transducers combine a series of advantages in comparison with other impedance-based
sensors, including rapid kinetics of detection, improved signal-to-noise ratio, quick establishment of
a steady-state response, low cost, and ease of miniaturization [118–120].
In a three-dimensional IDEA sensor, the general equivalent circuit that emulates the sensor
impedance should be represented by the following components (Figure 4C): RC is the contact
resistance introduced by wires and collector bars of the thin film electrodes; CIDS is the geometrical
(stray) capacitance between two electrodes; RS is the resistance between two electrodes of the array;
and CPEDL is a constant phase element representing the capacitance of the electrical double layer at the
electrode-water solution interface. It has been previously reported that in low conducting solutions,
surface conductivity plays an important role in this kind of sensors [114]. Therefore, RS is a parallel
combination of bulk solution resistance (RBULK) and the surface resistance (RSURF) (Figure 4C). It is
important to note that under experimental conditions it is often not possible to distinguish these two
elements in the impedance spectra. However, it is possible to fix the bulk solution conductivity and
attribute the changes in RS to surface resistance [25,114].
In summary, EIS represents an excellent technique for an accurate and sensitive biosensing of
bacteria. On top of the advantages previously described, EIS does not require the use of labeling
agents, and as such can be used to monitor bacterial binding on real-time. As a result of that, at present
EIS is considered one of the most promising electrochemical techniques, and its number of applications
in biosensing are rapidly increasing [123]. The final part of this review will focus on the most relevant
examples of this method to detect bacteria.
3.3. Examples of AMP-Based Biosensors for Bacterial Detection
In this section, relevant examples of bacterial detection are presented (Table 2). We will report
a few early studies using fluorescence spectroscopy (optical transducers) but the majority of works
will focus on impedimetric biosensors (EIS technique).
To the best of our knowledge, one of the first studies using an AMP as biorecognition element
was reported by Kulagina et al. in 2005 [94]. In this study, the authors described a fluorescence-based
biosensor functionalized with the AMP magainin I targeting Escherichia coli (E. coli) O157:H7 and
Salmonella typhimurium (S. typhimurium), which are both considered among the most dangerous
food-borne pathogens worldwide. The direct binding of magainin I on the sensor surface resulted in
LoD of 1.6× 105 and 6.5× 104 cells/mL for E. coli and S. typhimurium, respectively (Table 2). In contrast,
the immobilization of the peptide using biotin rendered sensors with lower affinity, thus indicating the
importance of an appropriate presentation of the AMP for the sensing activity.
In a subsequent study, this research group explored the use of a series of AMPs towards the
same two bacterial strains. In detail, in addition to magainin I, cecropin A, parasin, polymyxin B and
polymyxin E were immobilized on silanized glass slides at different peptide densities (Table 2) [91].
Interestingly, the AMPs displayed different degrees of affinity for the two bacteria (Table 3). It was also
notable that the majority of the peptides did not interact with non-pathogenic E. coli. These results
highlighted the fact that AMPs can be used to discriminate between different bacterial species, and even
between strains of the same species.
Another example following this approach evaluated a variety of AMPs (cecropin (A, B, and P),
parasin, magainin I, polymyxin (B and E), melittin, and bactenecin) for the biodetection of Cy3-labeled
Venezuelan equine encephalitis virus (VEE), vaccinia virus, Coxiella burnetti (C. burnetti) and Brucella melitensis
(B. melitensis) (Table 2) [92]. The majority of the immobilized AMPs detected VEE, vaccinia virus and
C. burnetti in a concentration-dependent manner, whereas B. melitensis preferably bound to polymyxin B,
polymyxin E, and bactenecin. No binding of any pathogen was observed on immobilized magainin I.
This work thus further strengthens the notion that AMPs may exert selectivity within distinct pathogens.
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Although these studies overall showed good affinity towards different bacterial strains, the LoD
obtained were in a range comparable with antibody-based assays. Moreover, these studies relied on
fluorescence microscopy, which implies the labeling of the bioreceptors/analytes prior to analysis.
As previously introduced, impedimetric biosensors represent a powerful label-free alternative to
reduce detection times and improve LoD in bacterial biosensing. As bacteria are generally electrically
charged, when they are immobilized on the electrode surface they produce variations in the electrical
impedance of the system. Bacterial attachment also implies a variation in interfacial impedance due to
changes in surface conductivity produced by their electrical charge or the surface layer capacitance.
Direct label-free impedance methods, which do not depend on bacterial growth or the production of
metabolites, provide very fast detection times and will be presented in this section [120,124].
Seminal experiments with electrochemical non-Faradic impedance technique with an AMP
immobilized on IDEAs were presented by Mannoor et al. in 2010 [97]. In this study, magainin I
was immobilized on gold microelectrodes via its C-terminal cysteine residue, and its capacity to bind
bacterial cells was evaluated by EIS. To this end, the biosensor was exposed to concentrations of
bacteria ranging from 103 to 107 CFU/mL. The variation in impedance was observed to be directly
proportional to the number of bacterial cells bound to the immobilized AMPs. Of note, the LoD of
the biosensor for E. coli O157:H7 was 103 CFU/mL (approx. 1 bacterium/µL). Other bacterial species
were tested to investigate the selectivity of the AMP-functionalized microelectrodes: Gram-negative
pathogenic (O157:H7) and non-pathogenic (ATCC 35218) E. coli, Gram-negative S. typhimurium and
Gram-positive Listeria monocytogenes (L. monocytogenes). Interestingly, the response of the biosensor
was clearly preferential towards pathogenic Gram-negative species of E. coli and S. typhimurium,
demonstrating the specificity of magainin I for these two pathogenic bacteria, in agreement with
previous reports [92,94]. The same research group described a few years later a wireless graphene-based
nanosensor integrated on a tooth for remote monitoring of respiration and bacteria detection in saliva
(Figure 5) [98]. The biosensing unit was a peptide construct based on a graphene-binding peptide
(GBP) and the AMP odorranin-HP (OHP).
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Figure 5. Graphene-based sensor for the remote (wireless) detection of bacteria. (a) Schematic
representation of the nanosensor, containing a graphene/silk-based biosensor coupled to a resonant
wireless coil; (b) Transfer of the nanosensor onto a tooth surface; (c) Illustration of the wireless signal
upon bacterial detection; (d) Magnification of the bacterial interaction with the AMP-coated graphene
platform. Reprinted by permission from Springer Nature-Nature Communications, from [98]. © 2012
Macmillan Publishers Limited.
F rrocen (Fc) and its derivatives are often used in electrochemic systems owing to their b eficial
ele trochemical properties [125]. In this regard, Li et al. described a novel bi sensor composed of
the conjugate Fc-magainin I on a gold electrode for the detection of pathog nic E. coli O157:H7 [101].
Non-pathogenic of E. coli K12, Staphylococcus epidermidis (S. epidermidis) and Bacillus subtilis (B. subtilis)
were also included in this study to evaluate the selectivity of the biosensor. As observed in previous
studies [92,94,97], magainin I showed selectivity for pathogenic E. coli. Accordingly, the sensor displayed
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the following trend of selectivity: pathogenic E. coli O157: H7 (LoD of 103 CFU/mL) > non-pathogenic
E. coli > the two Gram-positive species. A similar LoD (1.5 × 103 CFU/mL) for E. coli O157: H7 was
obtained using a synthetic AMP (GIGKFLHSAGKGKAFVGEIMKSC) coated on a gold electrode via its
C-terminal cysteine residue (Table 1) [95]. Interestingly, the sensor could be regenerated and used up
to 20 times, maintaining almost 80% of the signal response obtained on the first measurement and thus
demonstrating the good stability of the biosensing AMP.
As we commented before, the sensitivity and specificity of AMPs may decrease if the detection is
done in real samples, such as blood or milk. To overcome false positive signals from the non-specific
binding of proteins and others biomolecules present in food samples, Etayash et al. reported a new
impedance array analyzer that works at very low frequency to detect Gram-positive bacteria [100].
The AMP used was leucocin A, a naturally occurring AMP from class IIa bacteriocins, which possesses
high antibacterial potency a Gram-positive species such as L. monocytogenes. In detail, the AMP was
immobilized on interdigitated gold microelectrodes via its C-terminal carboxylic acid and was capable
of selectively detecting L. monocytogenes in contaminated milk samples with a LoD of 103 CFU/mL.
In another recent study, a microfluidic chip based on an electrical impedance microsensor array
functionalized with two species-specific synthetic AMPs (C16G2cys or G10KHc) was described [99].
Peptide immobilization on the surfaces was made via cysteine–gold interactions, and the resulting
biosensors efficiently detected Streptococcus mutans and Pseudomonas aeruginosa (P. aeruginosa) at
minimum concentrations of 105 CFU/mL in only 25 min.
To further improve the sensitivity (i.e., LoD) of impedimetric sensors, several recent approaches
have been described. For example, Liu et al. designed a multidomain AMP with the sequence
WK3(QL)6K2G3C for highly sensitive bacterial detection [103]. The antimicrobial activity of this
peptide was dependent on its conformation, which was a mixed of random coil (WK3) and beta-sheet
((QL)6K2) secondary structures. The peptide was bound to the gold electrodes via its C-terminal moiety
(G3C). This peptide allowed the detection of E. coli, P. aeruginosa, Staphylococcus aureus (S. aureus) and
S. epidermidis with a LoD of only 102 CFU/mL.
Another strategy is to use three-dimensional IDEA (3D-IDEA) devices [126], which have insulating
barriers separating the electrode digits and permit to considerably enhance the sensitivity of the
transducer compared to conventional (flat) IDEA sensors. The 3D geometry translates into a higher
capacity to monitor changes on the surface charge when a target molecule binds to the sensor.
In this regard, we recently reported the combination of miniaturized and integrated 3D-IDEA and
the AMP hLf1-11 for the impedimetric detection of periodontopathogenic bacteria (Figure 6) [104].
The peptide hLf1-11 was chosen for its well-known activity against Streptococcus sanguinis (S. sanguinis)
a primary colonizer in oral biofilms, as reported by us in several studies [19,127–129] and
immobilized on the biosensor using vapor-phase silanization. The developed biosensors very
efficiently detected S. sanguinis in both KCl samples (LoD: 3.5 × 101 CFU/mL) and artificial saliva
(LoD: 8.6 × 102 CFU/mL) at very short detection times (30 min). Of note, such low LoD are uncommon
for these types of sensors, especially in complex samples such as saliva (Table 2).
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Figure 6. Schematic representation of the biosensor design and its functionalization with the hLF1-11
peptide. 3D-IDEA electrodes were silanized in vapor phase with an epoxysilane. The hLf1-11 peptide
contains 3 parts: (i) an antibacterial domain (black), (ii) a spacer unit (blue), and (iii) a lysine residue that
acts as anchoring moiety (violet). The binding of S. sanguinis to the AMP-coated surface is measured
by EIS technique. Reprinted from [104], with permission from Elsevier. © 2016 Elsevier B.V.
Finally, third approach to improve the L D of AMP-based impedimetric se sors is to
use nanomaterials as signal amplifiers (see Section 2.3 for etails) [123,130,131]. For instance,
Andrade et al. recently developed a detection system combining CNT and the AMP clavanin A [102].
These nanostructured sensors were able to detect bacteria in a wide range of concentrations,
102–106 CFU/mL. Specifically, the biosensors showed LoD of 102 CFU/mL for E. coli and
Klebsiella pneumoniae (K. pneumonia) and of 103 CFU/mL for Enterococcus faecalis (E. faecalis) and
B. subtilis. Moreover, this system was able to differentiate between Gram-positive and Gram-negative,
and between pathogenic and non-pathogenic bacteria. In subsequent studies, this research group used
the same AMP, clavanin A, conjugated to gold nanoparticles [105]. Noteworthy, this method allowed
a linear range of detection from 101 to 104 CFU/mL and a LoD of only 10 CFU/mL for S. aureus,
E. faecalis, P. aeruginosa, S. typhimurium and E. coli. Such LoD is one of the lowest values described so
far for AMP-based impedimetric sensors in the literature (Table 2).
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Table 2. AMP-based sensors for bacterial detection.
AMP Sequence Bacteria Detected LoD(CFU/mL) Application Type of Transd. Sensor Structure Detection Time Ref.
Magainin I E. coli O157:H7;S. typhimurium
1.6 × 105;
6.5 × 104 cells/mL — FS
Silanized glass slide on
array-based biosensor 70 min [94]
Cecropin A, parasin,
magainin I,
polymyxin B and E
E. coli O157:H7;
S. typhimurium
See
Table 3
Detection of foodborne
contaminants FS
Glass slides-PDMS on a
mixed “sandwich” assay
(multi-AMP array)
— [91]
Cecropin (A, B, and P),
parasin, magainin I,
polymyxin (B and E),
melittin, bactenecin
C. burnetti;
B. melitensis; VEE;
vaccinia virus
5 × 105 cells/mL;
5 × 104;
<5 × 105 cells/mL;
<5 × 105
Detection of inactivated
targets of biodefense interest FS
Glass slides-PDMS on
array-based biosensor — [92]
Magainin I
E. coli O157:H7;
S. typhimurium 10
3
Detection of an infectious
outbreak from a broad
spectrum of
pathogenic species
EIS Gold surface-cysteineon IDEA — [97]
GBP + OHP
E. coli;
H. pylori;
S. aureus
103 in wireless
operation mode
Duodenal ulcers and
stomach cancers EIS
IDEA with graphene
resistive sensors in
a silk support
— [98]
Magainin I
E. coli O157:H7;
E. coli K12;
B. subtilis;
S. epidermis
103
Life-threatening
gastrointestinal infections EIS
Ferrocene-Magainin
conjugate on
a gold electrode
— [101]
Leucocin A L. monocytogenes;S. aureus 10
3 — EIS Gold surface- cysteamineon IDEA 20 min [100]
G10KHc,
C16G2cys
P. aeruginosa;
S. mutans 10
5 Infectious diseases EIS Gold surface-cysteine onmicrofluidic chip 25 min [99]
Clavanin A
K. pneumoniae;
E. faecalis;
E. coli;
B. subtilis
102;
102;
<103;
<103
Detect pathogens with high
resistance to conventional
antibiotics
EIS
Nanostructured sensor
based on carbon
nanotubes on
gold electrode
— [102]
GIGKFLHSAGKGKAFVGEIMKS E. coli O157:H7 1.5 × 103 Bacterial infections EIS
Mixed self-assembled
monolayer on a three
electrode system
30 min [95]
WK3(QL)6K2G3C
E. coli;
P. aeruginosa;
S. aureus;
S. epidermidis
102 Bacterial infections EIS Gold disk electrode — [103]
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Table 2. Cont.
AMP Sequence Bacteria Detected LoD(CFU/mL) Application Type of Transd. Sensor Structure Detection Time Ref.
hLF1-11 S. sanguinis
KCl:
3.5 × 101;
AS: 102
Bacterial infections EIS
3D-IDEA based on
silicon dioxide
insulating substrate
30 min [104]
Clavanin A
E. coli;
S. typhimurium;
E. faecalis;
S. aureus
~10 Dental infections EIS AuNPsCys 70 min [105]
AS: artificial saliva; EIS: electrochemical impedance spectroscopy; FS: fluorescence spectroscopy; AuNPsCys: cysteine-modified gold nanoparticles; PDMS: polydimethylsiloxane;
VEE: Venezuelan equine encephalitis virus; GBP: graphene-binding peptide; OHP: odorranin-HP.
Table 3. Limits of detection (LoD) (CFU/mL) of different types of AMPs for the detection of E. coli and S. typhimurium.
AMP E. coli S. typhimurium
Polymyxin B 1 × 105 5 × 105
Polymyxin E 5 × 105 5 × 106
Magainin 5 × 104 1 × 105
Cecropin A 1 × 105 5 × 105
Parasin 5 × 105 1 × 106
Data from [91].
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4. Conclusions
The field of biosensing is advancing rapidly and it is expected to provide technological solutions to
new challenges of our society. One of such challenges is the growing emergence of bacterial resistance
and the difficulty in treating pathogenic biofilms. In this regard, biosensors allow a rapid, cost-effective
and specific detection of bacterial cells, and thus will facilitate the identification and treatment of
infections at very early stages.
This review has particularly focused on the use of impedimetric biosensors containing AMPs
as biorecognition elements. AMPs have shown unique properties in comparison with other
“classical” bioreceptors such as enzymes or antibodies, including high sensitivity, stability and ease
of manufacturing. Moreover, we have shown that AMPs are also capable of achieving good levels of
specificity, discriminating between pathogenic and non-pathogenic bacteria or between Gram-positive
and Gram-negative species. In addition, we have shown that the sensitivity of AMP-based biosensors
can be finely tuned and improved by different strategies like the use of signal amplifiers, 3D-electrodes
or rationally engineering of the peptidic structure. Such approaches resulted in LoD as low as
10 CFU/mL, even in complex samples like saliva in very short detection times.
We have shown that AMP-impedimetric sensors combine excellent properties to produce robust,
label-free, rapid, sensitive, specific and cost-effective platforms for the early detection of bacterial
infections. However, the number of studies in this area is still limited. It is foreseen that more research
will shed light on the opportunities of these systems for technological transfer and its actual use in
clinical settings.
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